SEI Investments’s Oric Pharmaceuticals ORIC Stock Holding History

SEI Investments’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,054	Closed	-$67K	–	2710
2022 Q2	$67K	Buy	+15,054	New	+$60.1K	﹤0.01%	2591

Other funds holding ORIC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

SEI Investments's ORIC Position: Q3 2022 in Review

SEI Investments sold out of Oric Pharmaceuticals (ORIC) in Q3 2022, closing a stake of 15,054 shares — an estimated $67K sold.

SEI Investments first reported a position in ORIC in Q2 2022 and held it in 1 quarter. The position peaked at $67K in Q2 2022. 76 funds tracked by Wall St. Rank hold ORIC as of Q3 2022.

SEI Investments reported no remaining Oric Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
SEI Investments sold 15,054 Oric Pharmaceuticals shares in Q3 2022, an estimated $67K.
SEI Investments first reported a position in Oric Pharmaceuticals in Q2 2022 and held it in 1 quarter.
SEI Investments's Oric Pharmaceuticals position peaked at $67K in Q2 2022.
76 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2022.

Based on SEI Investments's 13F filing for Q3 2022, filed 14 Nov 2022.